Peter E. Lipsky
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 0.02%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Rheumatology 268
- Systemic Lupus Erythematosus Research 140
- Rheumatoid Arthritis Research and Therapies 120
- Immunology 260
- T-cell and B-cell Immunology 215
- Immunotherapy and Immune Responses 30
- Co-authors
- Thomas Dörner (57 shared papers)Laurie S. Davis (40 shared papers)Gabor G. Illei (14 shared papers)Thomas D. Geppert (25 shared papers)Amrie C. Grammer (71 shared papers)Lee S. Simon (9 shared papers)Ravinder Nath Maini (14 shared papers)Daniel E. Fürst (6 shared papers)
- Journals
- The Journal of Immunology (133 papers)Annals of the Rheumatic Diseases (32 papers)Arthritis Research & Therapy (26 papers)Journal of Clinical Investigation (25 papers)Cellular Immunology (13 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Peter E. Lipsky
670 papers receiving 47.1k citations
Peter E. Lipsky's Hit Papers
Peers
Comparison fields: 5 of 167
- Rheumatology 16.3k
- Immunology 12.8k
- Immunology and Allergy 1.2k
- Complementary and alternative medicine 1.8k
- Pharmacology 2.5k
Countries citing papers authored by Peter E. Lipsky
This map shows the geographic impact of Peter E. Lipsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Lipsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Lipsky more than expected).
Fields of papers citing papers by Peter E. Lipsky
This network shows the impact of papers produced by Peter E. Lipsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Lipsky. The network helps show where Peter E. Lipsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter E. Lipsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 683 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2000 | 2600 |
| 2 | Cyclooxygenase in biology and disease Hit paper breakdown → | 1998 | 2207 |
| 3 | Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Hit paper breakdown → | 1999 | 2021 |
| 4 | Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation Hit paper breakdown → | 2007 | 962 |
| 5 | 2006 | 676 | |
| 6 | Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis Hit paper breakdown → | 1999 | 665 |
| 7 | 2004 | 560 | |
| 8 | 2005 | 558 | |
| 9 | 2002 | 553 | |
| 10 | 2000 | 534 | |
| 11 | 2007 | 518 | |
| 12 | 2001 | 492 | |
| 13 | 2005 | 481 | |
| 14 | 2004 | 437 | |
| 15 | 2011 | 437 | |
| 16 | Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study Hit paper breakdown → | 2010 | 424 |
| 17 | 1998 | 412 | |
| 18 | 2000 | 395 | |
| 19 | 2005 | 389 | |
| 20 | 1995 | 388 |
About Peter E. Lipsky
Peter E. Lipsky is a scholar working on Rheumatology, Immunology, Immunology and Allergy, Complementary and alternative medicine and Nephrology, having authored 683 papers that have together received 50.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (215 papers), Systemic Lupus Erythematosus Research (140 papers), Rheumatoid Arthritis Research and Therapies (120 papers), Immunotherapy and Immune Responses (30 papers), Gout, Hyperuricemia, Uric Acid (26 papers), Natural Compounds in Disease Treatment (25 papers), Cell Adhesion Molecules Research (25 papers) and Cholesterol and Lipid Metabolism (17 papers). The work is most often cited by research in Rheumatology (16.3k citations), Immunology (12.8k citations), Immunology and Allergy (1.2k citations), Complementary and alternative medicine (1.8k citations) and Pharmacology (2.5k citations). Peter E. Lipsky has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Thomas Dörner, Laurie S. Davis, Gabor G. Illei, Thomas D. Geppert, Amrie C. Grammer, Lee S. Simon, Ravinder Nath Maini, Daniel E. Fürst, Michael H. Weisman and E. William St. Clair. Their work appears in journals such as The Journal of Immunology, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Journal of Clinical Investigation and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.